Dexamethasone Sodium Phosphate Injection, Solution
Product Images NDC 0404-9842

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Dexamethasone Sodium Phosphate (NDC 0404-9842). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula1.jpg (Formula1)

FDA Label Image

Image1.jpg (Image1)

This is a list of different dosages for a medication administered via intravenous injection/infusion. The dosages range from 2-6 mg/kg to 1 mg/kg depending on the author's recommendation. The medication is given to treat shock and requires repeat injections at various intervals depending on the recommended dosage.*

FDA Label Image

Image2.jpg (Image2)

This is a table showing the recommended amount of Dexamethasone Phosphate (in milligrams) to be injected at different sites of the body. The injection sites listed are large joints such as the knee, small joints such as the interphalangeal and temporomandibular joints, bursae, tendon sheaths, soft tissue infiltration, and ganglia.*

FDA Label Image

Image3.jpg (Image3)

Dexamethasone sodium phosphate injection, USP is a medication authorized for intravenous, intramuscular, intra-articular, intralesional and soft tissue administration. It is available in different fill volumes and pack sizes depending on the concentration. It comes in 4 mg/mL and 10 mg/mL concentrations and can be obtained in single-dose vials or multi-dose vials.*

FDA Label Image

Label1.jpg (Label1)

This is a description of Dexmethasone Sodium Phosphate injection, which is a medication given via injection for intramuscular or intravenous use only. The injection is sold in 10mg/ml multi-dose vials and requires protection from light. The injection must be kept at a controlled room temperature between 68°F to 77°F and should not be autoclaved or frozen. The packaging and distribution is managed by Henry Schein, Inc. No dosage information or usage instructions are provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.